Immunovant, Inc. IMVT Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s common stock shares issued?
- Immunovant, Inc. (IMVT) reported common stock shares issued of 203.3M in Q4 2025.
- How has Immunovant, Inc.'s common stock shares issued changed year-over-year?
- Immunovant, Inc.'s common stock shares issued increased by 38.1% year-over-year, from 147.2M to 203.3M.
- What is the long-term trend for Immunovant, Inc.'s common stock shares issued?
- Over 4 years (2021 to 2025), Immunovant, Inc.'s common stock shares issued has grown at a 14.8% compound annual growth rate (CAGR), from 98M to 170.1M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.